Phase III PRESTIGE-AF trial shows that direct oral anticoagulants significantly lower the risk of ischemic stroke in ...

Two randomized trials in China find that intra-arterial thrombolysis with urokinase or tenecteplase does not significantly ...

A blood test conducted in a prehospital setting may rapidly distinguish between ischemic and hemorrhagic stroke, potentially facilitating more rapid, targeted treatment. The test measures the ...

Following the onset of nonarteritic anterior ischemic optic neuropathy, regular stroke workup may be necessary.

PRESTIGE-AF is the first of the larger trials in this scenario to report results. More data are needed to help guide ...

The approval is based on results of the AcT trial, where tenecteplase was comparable to alteplase for safety and efficacy.

Hemorrhagic stroke has more than double the ... initial presentation vs those with thrombotic strokes (arterial ischemic stroke [AIS] or cerebral venous thrombosis [CVT]). The analysis included ...

Intra-arterial thrombolysis via urokinase following reperfusion by endovascular thrombectomy for stroke does not affect survival without disability.

Learn the key differences between stroke and migraine symptoms, from onset speed to pain patterns, and know exactly when to ...

Learn the seven critical warning signs of a stroke, from sudden numbness to vision problems, and why immediate action is ...

Medtronic also recently teamed with Tempus to assess the use of artificial intelligence to identify people eligible for ...

For patients with acute ischemic stroke whose symptoms began 4.5 to 24 hours earlier, alteplase is associated with a higher percentage of patients achieving a score of 0 or 1 on the modified Rankin ...